CAS 154026-93-4
:Acide hexanoïque, 6-chloro-3,5-dihydroxy-, ester 1,1-diméthyléthyle, (3R,5S)-
- tert-butyl (3R,5S)-6-chloro-3,5-dihydroxyhexanoate
Hexanoic acid, 6-chloro-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3R,5S)-
CAS :Formule :C10H19ClO4Couleur et forme :LiquidMasse moléculaire :238.7085(3R,5S)-tert-Butyl 6-chloro-3,5-dihydroxyhexanoate
CAS :(3R,5S)-tert-Butyl 6-chloro-3,5-dihydroxyhexanoate is a secondary metabolite that is used as a lipid-lowering drug. It is synthesized by an asymmetric synthesis of 3,5-dihydroxyhexanoic acid and tertiary butyl alcohol. The synthetic pathway starts with the conversion of diaminopentane phosphate to diaminopentane dihydrogen phosphate in the presence of sodium carbonate. This reaction produces a mixture of (2S,4S)- and (2R,4S) -enantiomers of diaminopentane dihydrogen phosphate. The (2S,4S) -enantiomer is then converted to (2R,4S) -enantiomer by dehydrogenase enzymes. Hydroxylation of the (2R,4S) -enantiomer occurs with the help of a lipase enzyme
Formule :C10H19ClO4Degré de pureté :Min. 95%Masse moléculaire :238.71 g/mol1,1-Dimethylethyl (3R,5S)-6-Chloro-3,5-dihydroxyhexanoate
CAS :Produit contrôléStability Hygroscopic
Applications (3R,5S)-6-Chloro-3,5-dihydroxyhexanoic Acid tert-Butyl Ester is an intermediate in the synthesis of Rosuvastatin (R700500), a selective, competitive HMG-CoA reductase inhibitor.
References Amidjojo, M., et al.: App. Microbiol. Biotechol., 69, 9 (2005);Formule :C10H19ClO4Degré de pureté :~90%Couleur et forme :NeatMasse moléculaire :238.71




